Adagio Medical Holdings (ADGM) Cash from Operations (2023 - 2026)

Adagio Medical Holdings (ADGM) has 4 years of Cash from Operations data on file, last reported at 4126000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations rose 42.78% year-over-year to 4126000.0; the trailing twelve-month figure through Mar 2026 stood at 21809000.0 (up 18.57% YoY), and the FY2025 full-year result was 19014000.0, down 41.17% from the prior year.
• Cash from Operations held at 4126000.0 in Q1 2026, from 4114000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 4114000.0 in Q4 2025 to a low of 7211000.0 in Q1 2025.
• A 4-year average of 6016000.0 and a median of 6473000.0 in 2024 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations decreased 7.0% in 2025 and surged 42.78% in 2026, its largest moves.
• Tracing ADGM's Cash from Operations over 4 years: stood at 7091000.0 in 2023, then grew by 10.34% to 6358000.0 in 2024, then soared by 35.29% to 4114000.0 in 2025, then declined by 0.29% to 4126000.0 in 2026.
• Business Quant data shows ADGM's Cash from Operations at 4126000.0 in Q1 2026, 4114000.0 in Q4 2025, and 7211000.0 in Q1 2025.